Paper3396014
Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of tumor induction in the prostate and testes and at the injection site.
Waalkes MP and 8 others. Cancer Res, 1988. Cited by 114 papers, by iCite.
Cite this record
ConductScience Library. Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of tumor induction in the prostate and testes and at the injection site. Papers, record 3396014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3396014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of tumor induction in the prostate and testes and at the injection site.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cadmium | Major topic |
| Prostatic Neoplasms | Major topic |
| Sarcoma, Experimental | Major topic |
| Testicular Neoplasms | Major topic |
| Animals | |
| Dose-Response Relationship, Drug | |
| Injections, Subcutaneous | |
| Male | |
| Pancreatic Neoplasms | |
| Precancerous Conditions | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40780533 | Carcinogenicity of some metals evaluated by the IARC Monographs: A synopsis of the evaluations of arsenic, cadmium, cobalt, and antimony. | Toxicol Appl Pharmacol | 2025 | https://conductscience.org/library/papers/40780533 | PubMed |
| 33129824 | Role of the PI3K/Akt pathway in cadmium induced malignant transformation of normal prostate epithelial cells. | Toxicol Appl Pharmacol | 2020 | https://conductscience.org/library/papers/33129824 | PubMed |
| 32951117 | Cadmium Exposure and Testis Susceptibility: a Systematic Review in Murine Models. | Biol Trace Elem Res | 2021 | https://conductscience.org/library/papers/32951117 | PubMed |
| 29662348 | Cadmium-induced testicular damage in a rat model of subchronic intoxication. | Reprod Med Biol | 2002 | https://conductscience.org/library/papers/29662348 | PubMed |
| 26873961 | Inference for the existence of hormetic dose-response relationships in toxicology studies. | Biostatistics | 2016 | https://conductscience.org/library/papers/26873961 | PubMed |
| 25673502 | Cadmium induces histone H3 lysine methylation by inhibiting histone demethylase activity. | Toxicol Sci | 2015 | https://conductscience.org/library/papers/25673502 | PubMed |
| 25646071 | Epigenetic effects of cadmium in cancer: focus on melanoma. | Curr Genomics | 2014 | https://conductscience.org/library/papers/25646071 | PubMed |
| 25272057 | A review of molecular events of cadmium-induced carcinogenesis. | J Environ Pathol Toxicol Oncol | 2014 | https://conductscience.org/library/papers/25272057 | PubMed |
| 23941782 | Cadmium modifies the cell cycle and apoptotic profiles of human breast cancer cells treated with 5-fluorouracil. | Int J Mol Sci | 2013 | https://conductscience.org/library/papers/23941782 | PubMed |
| 22472887 | Cadmium influences the 5-Fluorouracil cytotoxic effects on breast cancer cells. | Eur J Histochem | 2012 | https://conductscience.org/library/papers/22472887 | PubMed |
| 22457795 | Low-dose Cd induces hepatic gene hypermethylation, along with the persistent reduction of cell death and increase of cell proliferation in rats and mice. | PLoS One | 2012 | https://conductscience.org/library/papers/22457795 | PubMed |
| 22448262 | Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. | PLoS One | 2012 | https://conductscience.org/library/papers/22448262 | PubMed |
| 20003241 | Cadmium burden and the risk and phenotype of prostate cancer. | BMC Cancer | 2009 | https://conductscience.org/library/papers/20003241 | PubMed |
| 19343115 | A perspective on the scientific, philosophical, and policy dimensions of hormesis. | Dose Response | 2009 | https://conductscience.org/library/papers/19343115 | PubMed |
| 19330138 | The maturing of hormesis as a credible dose-response model. | Nonlinearity Biol Toxicol Med | 2003 | https://conductscience.org/library/papers/19330138 | PubMed |
| 18648620 | Hormesis: implications for cancer risk assessment. | Dose Response | 2006 | https://conductscience.org/library/papers/18648620 | PubMed |
| 17450215 | Hormesis and its place in nonmonotonic dose-response relationships: some scientific reality checks. | Environ Health Perspect | 2007 | https://conductscience.org/library/papers/17450215 | PubMed |
| 17107829 | Hormesis: a new religion? | Environ Health Perspect | 2006 | https://conductscience.org/library/papers/17107829 | PubMed |
| 16961932 | The toxicity of cadmium and resulting hazards for human health. | J Occup Med Toxicol | 2006 | https://conductscience.org/library/papers/16961932 | PubMed |
| 16203233 | Fundamental flaws of hormesis for public health decisions. | Environ Health Perspect | 2005 | https://conductscience.org/library/papers/16203233 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3396014
GET https://conductscience.org/api/papers/v1/3396014/cited_by?page=2